Amphastar's Management Team takes pride in the Company's "3H" commitment to "High Quality, High Efficiency and High Technology". In keeping with this pledge of excellence to the consumer, Amphastar will continue to invest in state-of-the-art equipment, research & development, facilities, and the advancement of their employees. Amphastar is committed to providing an environment that empowers employees to realize their full potential through the achievement of both their professional and personal goals.

Amphastar Pharmaceuticals, Inc., established in 1996, is a specialty and generic pharmaceutical company focusing on  injectable, inhalation, and other categories of pharmaceutical products. Amphastar's state-of-the-art, aseptic, cGMP compliant facilities develop, manufacture, and market innovative proprietary and generic products using new technologies and delivery systems.

Amphastar is staffed with highly dedicated and experienced professionals who are committed to providing quality products at competitive prices.

We currently manufacture and sell approximately 10 products and are continuing to develop a portfolio of generic and branded products that target large markets with high technical barriers to entry. We are capable of producing a broad range of dosage formulations. We have long standing relationships with all the major group purchasing organizations and drug wholesalers in the U.S. that deliver products to our end markets, which enables us to rapidly introduce new products and quickly establish significant market share.

Core Sales Territory: North America

Core Operation: API Manufacture, Finished Dose Manufacture, Sales and Marketing, Distribution

Number of molecules sold: 10

Company's rating: